Plain-English translation of NCT06329739 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson Disease research guide →This research study is trying to understand how genetic differences affect the way Parkinson's disease progresses, particularly how it impacts thinking, memory, and behavior. Researchers will follow people who are already taking dopamine medications (which are standard treatment for Parkinson's) and compare those who have a genetic mutation related to Parkinson's with those who don't. By doing this, they hope to learn whether knowing someone's genetic makeup can help predict how their symptoms might develop.
Scientists have learned that Parkinson's disease can be caused by different genetic mutations, but they don't yet fully understand how these genetic differences affect thinking and behavior in individual patients. This study exists to fill that gap so doctors can eventually use genetic information to better predict and manage Parkinson's symptoms.
You likely qualify if…
You likely don't qualify if…
You would come in for an initial assessment at the start of the study, then return for follow-up visits once a year for five years. At each visit, you'll complete various tests, questionnaires, and standard clinical assessments designed to measure thinking, memory, mood, and behavior. The study is observational, meaning researchers are watching and measuring—not testing a new medication or treatment—to see how your symptoms change over time.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Italy